Inveready, with 150 investors and a portfolio of 80 biotech and technology companies, is launching a €40-million fund, called Inveready Convertible Finance. Inveready will do so by issuing convertible bonds that can be exchanged for shares to invest in twenty newly created start-ups anywhere in the world. These start-ups must be traded on alternative markets, preferably the Spanish MAB or French Alternext.

"This fund will allow investors to make a controlled entry into a highly volatile market," explains Inveredy partner Carlos Conti. The company has already launched two debt funds and seeks to attract institutional investors, insurance companies and pension funds.

More information on the Expansión website (Spanish press)

Photo: Carlos Conti, partner of Inverady - © Expansión, Elena Ramon